Enlitic, which uses machine learning to improve healthcare diagnostics, will work with new investor Capitol Health to expand into Asia and Australia.
US-based medical diagnostics technology developer Enlitic raised $10m in a series B round led by radiology services provider Capitol Health on Tuesday.
Founded in August 2014, Enlitic uses machine learning to analyse x-ray images in order to identify ailments such as lung cancer at an early-stage, increasing a patient’s odds of survival, while at the same time reducing the occurrence of false positives.
Australia-based Capitol Health will support Enlitic’s expansion into Australia and Asia as part of the deal, integrating…
